CYP2C19 and obesity due to melanocortin 4 receptor deficiency: However, the CYP2C19 metabolic enzyme activity decreased in patients with obesity, and the auto-inhibition of CYP2C19 may be limited (similar to PMs); therefore, a comparable exposure was observed after single or repeated doses.